Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes

Fig. 2

Epicardial adipose tissue (EAT) metabolism: SUV max and SUV mean at left circumflex artery level (Cx) and at the roof of the left atrium (RLA) in placebo (A) and dapagliflozin group (B); SUV mean (C) and SUV max (D) of EAT at right coronary artery/left circumflex artery/ anterior interventricular artery /roof of the left atrium (average) in placebo and dapagliflozin group

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840